TEHRAN, Oct. 23 (Press Shia) – Iranian researchers have developed highly accurate and cost-efficient biosensors that can detect cancers that require tissue sampling.
Dr. Mohammad Abdolahad, the project manager of ‘biosensor for detection of metastatic phase of cancer’ told Mehr News that his team has been successful in developing various biosensors in the past six years, but their latest system is more cost-efficient for cancer detection.
He maintained that the biosensors have been designed and developed via nanotechnology, adding most of which can be used at a research scale.
“Our latest product is in fact the tenth generation of cancer sensors and is able to detect various kinds of cancers in the shortest time possible and with the highest accuracy,” he said.
According to him, the biosensor has so far yielded successful results in detecting cancers that require tissue sampling such as breast cancer, prostate cancer and caner in lymph nodes.
“The biosensor is simple to use, highly cost-efficient, easily accessible and very accurate,” he said.
He explained the applications of the cancer detection sensor as, “assessing the metastatic growth in cancer cells, evaluating the effects of anticancer drugs on cancer cells, and studying the interaction of cancer cells with vascular cells.”
He stressed that the biosensor has been 100% accurate in detecting cancers in patients whose cancers have been previously detected through current tests, and even successful in detecting cancer where current tests had failed to do so.
“This system has been patented in Iran and the US, and no other country has yet the technology to develop such a biosensor,” he said.